Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

The microbiome plays a significant role in various diseases and health issues. Discover how Kaleido is pioneering a unique method to transform the potential of the microbiome into effective patient solutions. Comprising over 30 trillion microbes, the human microbiome includes a diverse array of organisms such as bacteria, viruses, archaea, and fungi that inhabit both the exterior and interior of the human body. In recent years, there has been a remarkable surge in research focusing on the microbiome's influence on human health, linking it to conditions such as cardiovascular disease, cancer, diabetes, Parkinson’s disease, and allergies. This intricate microbial community has been likened to a "newly discovered organ," highlighting its significance. Just as many human organs command substantial investments for therapies that modify physiology, the microbiome represents a largely unexplored territory in the realm of healthcare. Addressing this frontier could unlock new therapeutic avenues and enhance overall health outcomes.

Description

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

Azure Marketplace

Integrations

Azure Marketplace

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

Kaleido

Founded

2015

Country

United States

Website

kaleido.com/platform/

Vendor Details

Company Name

Lunit

Country

United States

Website

www.lunit.io/en

Product Features

Product Features

Alternatives

Alternatives

Healnet Reviews

Healnet

Healx
Oncora Reviews

Oncora

Oncora Medical
The Galen Platform Reviews

The Galen Platform

Ibex Medical Analytics